Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Cross-reactivity00:42

Cross-reactivity

Overview
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pyridostigmine as a therapeutic option for pediatric gastrointestinal dysmotilities in ATR-X syndrome. Case report and literature review.

Frontiers in pediatrics·2025
Same author

Multidisciplinary clinical guidelines in proactive monitoring, early diagnosis, and effective management of trastuzumab deruxtecan (T-DXd)-induced interstitial lung disease (ILD) in breast cancer patients.

ESMO open·2023
Same author

The Future of Breast Cancer Research in the Survivorship Field.

Oncology and therapy·2023
Same author

Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review.

Translational oncology·2020
Same author

Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning.

Seminars in cancer biology·2018
Same author

Immuno-oncology-101: overview of major concepts and translational perspectives.

Seminars in cancer biology·2018
Same journal

Early first-trimester CMV screening in a regional perinatal network: a multicenter descriptive study.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2026
Same journal

Maternal and neonatal outcomes of intrahepatic cholestasis of pregnancy in twin pregnancies: a systematic review and meta-analysis.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2026
Same journal

Clinical and immunological characteristics associated with adverse perinatal outcomes among pregnant people living with HIV: a retrospective cohort study.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2026
Same journal

Retraction statement: rupture of the pregnant uterus - a 20-year review.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2026
Same journal

Retraction statement: a new conservative surgical approach for placenta accreta spectrum in a low-resource setting.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2026
Same journal

Response to the letter regarding "cervical length and fetal fibronectin for the identification of true spontaneous onset of labor".

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2026
See all related articles

Related Experiment Video

Updated: Jun 8, 2026

Measuring Lactase Enzymatic Activity in the Teaching Lab
04:41

Measuring Lactase Enzymatic Activity in the Teaching Lab

Published on: August 6, 2018

Cow's milk protein allergy.

C Solinas1, M Corpino, R Maccioni

  • 1Children and Mother Care Department, Paediatrics Unit, S. Barbara Hospital, Iglesias.

The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
|September 15, 2010
PubMed
Summary
This summary is machine-generated.

Cow's milk protein allergy (CMPA) is an immune reaction affecting children, often outgrown by early adulthood. Diagnosis involves history, tests, and diet, with hydrolyzed formulas recommended for management.

More Related Videos

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)
13:00

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)

Published on: July 31, 2021

Related Experiment Videos

Last Updated: Jun 8, 2026

Measuring Lactase Enzymatic Activity in the Teaching Lab
04:41

Measuring Lactase Enzymatic Activity in the Teaching Lab

Published on: August 6, 2018

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)
13:00

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)

Published on: July 31, 2021

Area of Science:

  • Pediatric Allergy and Immunology
  • Gastroenterology
  • Clinical Nutrition

Background:

  • Cow's milk protein allergy (CMPA) impacts 2-7.5% of children, with most developing tolerance by age 4.
  • CMPA involves IgE or non-IgE mediated immune responses to milk proteins like casein and whey.
  • Symptoms can be immediate or delayed, necessitating accurate diagnosis.

Purpose of the Study:

  • To outline the diagnostic approaches for CMPA.
  • To detail the dietary management strategies for infants and children with CMPA.
  • To provide evidence-based recommendations for formula selection in CMPA cases.

Main Methods:

  • Diagnosis relies on detailed medical history, skin prick tests, patch tests, laboratory assessments, elimination diets, and oral food challenges.
  • Dietary management involves strict elimination of cow's milk protein.
  • Nutritional support utilizes extensively hydrolyzed whey or casein formulas, amino acid-based formulas, or soy formulas.

Main Results:

  • Extensively hydrolyzed whey or casein formulas are the first-line choice for mild to moderate CMPA.
  • Amino acid-based formulas are recommended for severe CMPA or cases unresponsive to hydrolyzed formulas.
  • Tolerance development is common, with 51% resolving within 2 years and 80% within 3-4 years.

Conclusions:

  • CMPA diagnosis requires a multi-faceted approach combining clinical history and objective testing.
  • Appropriate formula selection is crucial for effective CMPA management, with hydrolyzed and amino acid-based options offering distinct benefits.
  • Early diagnosis and tailored dietary interventions facilitate tolerance development and improve outcomes for affected children.